{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Entangled Health with Thomas Ehmer | Quantum Biology, Consciousness & the Future of Medicine","title":"Quantum Drug Discovery & Healthcare — Gopal Karemore (IBM Quantum)","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/508185db\"></iframe>","width":"100%","height":180,"duration":4006,"description":"Entangled Health with Thomas Ehmer is a long-form podcast and research-media project exploring quantum biology, quantum computing, AI, biotechnology, consciousness research, and the future of medicine.\nWe distinguish established evidence, emerging research, and frontier hypotheses.\nIBM's Global Quantum Lead for Healthcare reveals what's actually working in quantum drug discovery. Dr. Gopal Karemore explains why \"quantum advantage\" isn't hype, IBM and RIKEN's quantum systems solved drug discovery problems in hours that classical computers couldn't crack in years. Topics: AlphaFold's limitations in protein folding, 90% clinical trial failure rates, quantum-AI hybrid approaches for precision medicine. From IBM quantum computers to pharmaceutical R&D transformation. Essential listening for pharma executives, clinical scientists, and healthcare innovators. \nGet ready for a front-row seat at the future of medicine. Dr. Gopal Karemore, IBM’s Global Quantum Lead for Healthcare & Life Sciences, joins Entangled Health for a no-BS dive into what’s actually working in quantum drug discovery, where AI hits a wall (looking at you, AlphaFold), and how true scientific breakthroughs happen when physics, biology, and human curiosity collide.\nIn this episode, you’ll hear why “quantum advantage” is more than hype, IBM’s quantum computers, in tandem with Japan’s RIKEN and the legendary Fugaku supercomputer, just solved a drug discovery problem in two hours that would have taken classical machines years. Gopal breaks down the real advances and the hype, from protein folding’s unsolved mysteries, to the 90% failure rate in clinical trials, to the promise of quantum walks and supercomputing for designing tomorrow’s medicines.\nIt’s not just theory. We talk about:\nThe blind spots that leave AlphaFold and generative AI scratching at the surface, while quantum tackles the hard stuff: transition metals, allosteric modulation, disordered proteins, and rare diseases.\nWhat it means to actually...","thumbnail_url":"https://img.transistorcdn.com/lCt3zpiGGmpGHmssNr4igN-qUfa10YZigi_VXkvJdSY/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xYTU5/YTAwNGJmZTFiMjRk/YWM1MTJiOGQ3Mzc2/N2Y1Mi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}